Dr. Srdan Verstovsek, MD, PhD
- Medicare services, 2023
- 141
- Part D claims, 2023
- 12
- Publications
- 469
- Clinical trials
- 9
- Hospital affiliations
- 1
- Practice address
- 20480 Market Street, Onancock, VA 23417
- Practice phone
- Call (757) 414-8000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Verstovsek's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Srdan Verstovsek is a medical oncologist in Onancock, Virginia
Dr. Verstovsek practices at Riverside Shore Memorial Hospital in Onancock, Virginia, part of Riverside Health System.
Dr. Verstovsek's NPI, 1598864100, was assigned on September 21, 2006. Dr. Verstovsek graduated from University of Zagreb Faculty of Medicine in 1992. Dr. Verstovsek holds Texas license K8552.
- NPI
- 1598864100NPI Registry (opens in a new tab)
- NPI enumeration date
- September 21, 2006
- NPI status
- Active
- Practice phone
- (757) 414-8000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 60
- Medical school graduation
- 1992
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Srdan Verstovsek practices at Riverside Shore Memorial Hospital in Onancock, Virginia
Dr. Verstovsek's primary practice is Riverside Shore Memorial Hospital, at 20480 Market Street, Onancock, VA 23417 in Accomack County. The practice phone is (757) 414-8000.
- Riverside Shore Memorial Hospital20480 Market Street, Onancock, VA 23417 · Accomack CountyPhone(757) 414-8000
Source: Dmand AI Affiliation Data
Dr. Srdan Verstovsek is affiliated with 1 site of care
Dr. Verstovsek's primary practice is Riverside Shore Memorial Hospital in Onancock, Virginia, part of Riverside Health System.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Srdan Verstovsek's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Verstovsek practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Riverside Shore Memorial Hospital | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Riverside Health System and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Srdan Verstovsek is one of 99 medical oncologists in Virginia
Medical oncology is Dr. Verstovsek's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dmand AI has Dr. Verstovsek's licenses on file in 2 states: Texas and Oklahoma.
Specialties and state licenses
- Medical oncology, TexasPrimary
- Oklahoma license
Clinical focus
Dmand AI lists anemia, breast cancer, chronic leukemia and prostate cancer among the conditions Dr. Verstovsek treats.
Medical oncologists near Dr. Verstovsek
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Srdan Verstovsek billed Medicare for 141 services in 2023
CMS data shows 141 Medicare services from Dr. Verstovsek across 2 procedure codes in 2023. Medicare paid $10,080 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Verstovsek's Medicare services by type, 2022 to 2023
- 2022
- 2023
- Office and hospital visits
- 2022: 1,0872023: 14187%
Dr. Verstovsek compared with the Virginia median for medical oncologists, 2023
- Dr. Verstovsek
- Virginia median
- Medicare services
- 141vs 56675% below
- Part D claims
- 12vs 30396% below
Medians across 96 medical oncologists in Virginia with Dmand AI profiles that report each measure.
Dr. Verstovsek's most billed Medicare procedure codes, 2023
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Verstovsek?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Verstovsek and other medical oncologists in Virginia.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Srdan Verstovsek's patients have a median age of 76
Across all payers, Dmand AI patient panel data puts Dr. Verstovsek's median patient age at 76, with 33% women.
Dr. Verstovsek's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 76
Patient panel by sex, all payers
- Women33%
- Men67%
Source: Dmand AI Patient Panel Data
Dr. Srdan Verstovsek wrote 12 Medicare Part D claims in 2023
In 2023, Dr. Verstovsek wrote 12 Medicare Part D claims. They cover 1 drug, with $215,265 in total drug cost. In 2022, CMS named 123 claims across 6 drugs.
Dr. Verstovsek's most prescribed drugs by claims, 2023
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2022 to 2023
- 2022
- 2023
- Claims for drugs CMS names
- 2022: 1232023: 1290%
Drugs named by CMS: 1 in 2023, 6 in 2022.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Srdan Verstovsek has 469 publications on record
Dmand AI links 469 papers to Dr. Verstovsek, published from 2002 to 2025. 2017 was the busiest year, with 52. The most frequent topics are Primary Myelofibrosis, Janus Kinase 2 and Pyrimidines. Dr. Verstovsek has published most often in Cancer. Dr. Verstovsek's most frequent co-authors are Hagop M. Kantarjian, MD, Ruben Anthony Mesa, MD and Prithviraj Bose, MD.
Dr. Verstovsek's papers by year, 2016 to 2025
Topics Dr. Verstovsek writes about most
- Primary Myelofibrosis
- Janus Kinase 2
- Pyrimidines
- Myeloproliferative Disorders
- Nitriles
- Protein Kinase Inhibitors
- Pyrazoles
- Polycythemia Vera
Dr. Verstovsek's most frequent co-authors
- Hagop M. Kantarjian, MD85 shared papers
- Ruben Anthony Mesa, MD55 shared papers
- Prithviraj Bose, MD54 shared papers
Recent publications by Dr. Verstovsek
Haematologica
See who Dr. Verstovsek researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Verstovsek works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Srdan Verstovsek has worked on 9 clinical trials
Dmand AI links Dr. Verstovsek to 9 clinical trials, 8 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Primary Myelofibrosis, Thrombocythemia, Essential and Myeloproliferative Disorders. M.D. Anderson Cancer Center sponsors the most, 4.
Clinical trials with Dr. Verstovsek by phase
- NonePhase 1: no trials
- 8Phase 2: 8 trials
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Conditions in Dr. Verstovsek's trials
- Primary Myelofibrosis
- Thrombocythemia, Essential
- Myeloproliferative Disorders
- Thrombocytosis
- Eosinophilia
Investigators on the most trials with Dr. Verstovsek
Recent clinical trials with Dr. Verstovsek
Open-Label Roll-Over Study to Assess the Long-Term Safety and Efficacy of Ruxolitinib in Subjects With Myelofibrosis (opens in a new tab)
An Open-label, Phase IIa Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral GB2064 (a LOXL2 Inhibitor) in Participants With Myelofibrosis (MF) (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Srdan Verstovsek received $647,644 in industry payments from 2016 to 2023
CMS Open Payments shows 350 general payments to Dr. Verstovsek from 24 drug and device companies from 2016 to 2023. Consulting fees make up the largest share, 63% of the total. Incyte Corporation paid the most, $287,959. It also lists 6 research payments totaling $8,929 from 2017 to 2024.
General payments to Dr. Verstovsek by program year, 2016 to 2023
General payments to Dr. Verstovsek by kind, 2016 to 2023
- Consulting fees$408,13463%
- Speaker and faculty fees$168,68626%
- Travel and lodging$33,2045%
- Honoraria$22,8634%
- Other$10,2012%
Companies that paid Dr. Verstovsek the most, 2016 to 2023
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Srdan Verstovsek graduated from University of Zagreb Faculty of Medicine
Dr. Verstovsek graduated from University of Zagreb Faculty of Medicine in 1992.
- Medical school
Source: Dmand AI Professional Profile Data
Dr. Srdan Verstovsek accepts plans from 4 insurance carriers
Dr. Verstovsek is in network with 4 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.
- Aetna
- Excellus BlueCross BlueShield
- Blue Cross Blue Shield of Michigan
- Elevance
Plan types Dr. Verstovsek accepts, by number of carriers
- HMO4
- POS3
- PPO3
- EPO2
- Medicare2
Source: Dmand AI Insurance Network Data
Sources for Dr. Srdan Verstovsek's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Srdan Verstovsek
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Srdan Verstovsek's NPI number?
Dr. Srdan Verstovsek's NPI number is 1598864100. It was assigned on September 21, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Srdan Verstovsek?
Dr. Srdan Verstovsek is a medical oncologist in Onancock, Virginia. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Srdan Verstovsek practice?
Dr. Verstovsek practices at 20480 Market Street, Onancock, VA 23417. Dr. Verstovsek's primary practice is Riverside Shore Memorial Hospital in Onancock, Virginia, part of Riverside Health System.
What is Dr. Srdan Verstovsek's office phone number?
The practice phone on file for Dr. Verstovsek is (757) 414-8000.
What is Dr. Srdan Verstovsek's medical license number?
Dr. Verstovsek holds Texas license K8552, one of the licenses on file in 2 states.
Which states has Dr. Srdan Verstovsek been licensed in?
Dmand AI has state licenses on file for Dr. Verstovsek in Texas (1999 to 2026) and Oklahoma (2020 to 2021).
Which hospitals is Dr. Srdan Verstovsek affiliated with?
Dr. Verstovsek practices at Riverside Shore Memorial Hospital in Onancock, Virginia.
Does Dr. Srdan Verstovsek accept Medicare?
Yes. CMS data shows Dr. Verstovsek billed Medicare for 141 services in 2023.
What services does Dr. Srdan Verstovsek bill to Medicare?
In 2023, Dr. Verstovsek's most billed Medicare services were office visit, established patient (99214) and hospital inpatient care (99233).
Where did Dr. Srdan Verstovsek go to medical school?
Dr. Verstovsek graduated from University of Zagreb Faculty of Medicine in 1992.
Show 6 more questionsShow fewer questions
What drugs does Dr. Srdan Verstovsek prescribe most?
In 2023 Medicare Part D data, Dr. Verstovsek's most prescribed drugs by claims were Jakafi.
Has Dr. Srdan Verstovsek received payments from drug or device companies?
CMS Open Payments shows $647,644 in general payments to Dr. Verstovsek from 24 companies from 2016 to 2023. The largest total came from Incyte Corporation.
How long has Dr. Srdan Verstovsek been practicing?
Dr. Verstovsek graduated from medical school in 1992, 34 years ago.
Does Dr. Srdan Verstovsek do research?
Dmand AI links 469 publications to Dr. Verstovsek, published from 2002 to 2025. Dr. Verstovsek has worked on 9 clinical trials.
Who does Dr. Srdan Verstovsek publish with?
Dr. Verstovsek's most frequent co-authors are Hagop M. Kantarjian, MD (85 shared papers), Ruben Anthony Mesa, MD (55 shared papers) and Prithviraj Bose, MD (54 shared papers).
What insurance does Dr. Srdan Verstovsek accept?
Dr. Verstovsek is in network with 4 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.
Selling to medical oncology practices?
See medical oncologists in Virginia by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card